QbTest workshop at Eunethydis 2012

Qbtech are delighted to be running a short course at the Eunethydis International Conference in Barcelona on the 23rd of May. Chaired by Professor Edmund Sonuga-Barke, the course is entitled “Medication Optimisation in ADHD”, we will discuss the challenges of optimisation and how objective measurement can help. Eunethydis brings together leading academics and clinicians in the field of ADHD, if you are attending please join us in room 133+134 at 10.30am on the 23rd of May.

Objective tests in neuropsychology

Qbtech provides objective test systems that add depth and objective support to each clinical decision.

Today, most testing are still made using subjective measures, manual testing and rating scales. QbTest and PDMonitor are well documented and widely used systems that support clinical decisions with objective data, assist in evaluating treatment effects and improve dialogue with patients and their families in leading clinics throughout Europe.

QbTest is unique in that it objectively measures all three core signs of ADHD – hyperactivity, inattention and impulsivity in patients between 6 and 60 years of age. The test system is used to support diagnosis and to show response to and progress of treatment, regardless of whether the therapy is pharmacological, psychological therapies, counseling or a combination.

PDMonitor is an objective method for quantifying motor and non-motor parameters and gives rapid, clear and objective results of patient mobility in a repeatable way. The test results are used as a part of the diagnosis and follow-up of patients suffering from Parkinson’s disease.

Are you a patient and about to do a QbTest?

Please read the patient information to find more information about the test, how it is performed and what you can expect.